{ "labelLang" : "hun", "responseDate" : "2024-03-29 15:41", "content" : { "otype" : "JournalArticle", "mtid" : 25034186, "status" : "APPROVED", "published" : true, "comment" : "Faculty of Nursing, University of Manitoba, Winnipeg, Man., Canada \n Department of Pediatrics, Faculty of Medicine, University of Manitoba, Winnipeg, Man., Canada \n St Boniface General Hospital, Winnipeg, Man., Canada \n Department of Biological Sciences, Faculty of Science, University of Manitoba, Winnipeg, Man., Canada \n Cited By :7 \n Export Date: 3 April 2020 \n Correspondence Address: Askin, D.F.; Faculty of Nursing, University of Manitoba, Winnipeg, Man., Canada; email: debbie_fraser@umanitoba.ca", "unhandledTickets" : 0, "oldTimestamp" : "2015-09-21T10:56:44.000+0000", "deleted" : false, "oldId" : 15034186, "lastRefresh" : "2023-04-24T10:34:50.977+0000", "lastModified" : "2015-09-21T10:56:44.000+0000", "created" : "2015-09-21T10:50:34.000+0000", "creator" : { "otype" : "Author", "mtid" : 10002567, "link" : "/api/author/10002567", "label" : "Balla György (Csecsemő- és gyermekgyógyászat)", "familyName" : "Balla", "givenName" : "György", "published" : true, "oldId" : 10002567, "snippet" : true }, "lastDuplumSearch" : "2023-04-24T10:32:30.378+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Askin, DF", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 42008369, "link" : "/api/authorship/42008369", "label" : "Askin, DF", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Askin", "givenName" : "DF", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 73042140, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 42008370, "link" : "/api/authorship/42008370", "label" : "Diehl-Jones, W", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Diehl-Jones", "givenName" : "W", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 73042139, "snippet" : true } ], "title" : "Retinopathy of Prematurity", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 9719748, "link" : "/api/publicationidentifier/9719748", "label" : "DOI: 10.1016/j.ccell.2009.01.002", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.ccell.2009.01.002", "realUrl" : "https://doi.org/10.1016/j.ccell.2009.01.002", "published" : false, "oldId" : 10163300, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 9719747, "link" : "/api/publicationidentifier/9719747", "label" : "Scopus: 65549094046", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "65549094046", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-65549094046", "published" : false, "oldId" : 10163299, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 14822676, "link" : "/api/publicationidentifier/14822676", "label" : "PubMed: 19460665", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "NO", "idValue" : "19460665", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19460665&dopt=Abstract", "published" : false, "oldId" : 3348896, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 10029233, "link" : "/api/journal/10029233", "label" : "CRITICAL CARE NURSING CLINICS OF NORTH AMERICA 0899-5885 1558-3481", "pIssn" : "0899-5885", "eIssn" : "1558-3481", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 10029233, "snippet" : true }, "volume" : "21", "issue" : "2", "firstPage" : "213", "lastPage" : "233", "firstPageOrInternalIdForSort" : "213", "pageLength" : 21, "publishedYear" : 2009, "digital" : null, "printed" : null, "sourceYear" : 2015, "packet" : "542574", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : false, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-04-24", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 3, "citedCount" : 3, "referenceList" : "Lad, E.M., Nguyen, T.C., Morton, J.M., Retinopathy of prematurity in the United States (2008) Br J Ophthalmol, 92 (3), pp. 320-325; \n\nTerry, T.L., Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens (1942) Am J Ophthalmol, 25 (2), pp. 203-204; \n\nPatz, A., Hoeck, L.E., DeLaCruz, E., Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations (1952) Am J Ophthalmol, 35, pp. 1248-1253; \n\nKinsey, V.E., Cooperative study of retrolental fibroplasia and the use of oxygen (1956) Arch Ophthalmol, 56, pp. 481-543; \n\nCross, K.W., Cost of preventing retrolental fibroplasia (1973) Lancet, 2 (835), pp. 954-956; \n\nPhelps, D.L., Retinopathy of prematurity: an estimate of visual loss in the United States (1981) Pediatrics, 67 (6), pp. 924-925; \n\nPalmer, E.A., Flynn, J.T., Hardy, R.J., Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group (1991) Ophthalmology, 98 (11), pp. 1628-1640; \n\nSteinkuller, P.G., Du, L., Gilbert, C., Childhood blindness (1999) J AAPOS, 3 (1), pp. 26-32; \n\nGilbert, C., Rahi, J., Eckstein, M., Retinopathy of prematurity in middle-income countries (1997) Lancet, 350 (9070), pp. 12-14; \n\nSaugstad, O.D., Oxygen and retinopathy of prematurity (2006) J Perinatol, 26, pp. S46-S50; \n\nGilbert, C., Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control (2008) Early Hum Dev, 84 (2), pp. 77-82; \n\nGilbert, C., Fielder, A., Gordillo, L., Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs (2005) Pediatrics, 115 (5), pp. e518-e525. , International NO-ROP Group; \n\nFleck, B.W., McIntosh, N., Pathogenesis of retinopathy of prematurity and possible preventative strategies (2008) Early Hum Dev, 84, pp. 83-88; \n\nGood, W.V., Hardy, R.J., Dobson, V., The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study (2005) Pediatrics, 116 (1), pp. 15-23. , Early Treatment for Retinopathy of Prematurity Cooperative Group; \n\nHardy, R.J., Palmer, E.A., Dobson, V., Risk analysis of prethreshold ROP (2003) Arch Ophthalmol, 121, pp. 1699-1701; \n\nO'Connor, M.T., Vohr, B.R., Tucker, R., Is retinopathy of prematurity increasing among infants less than 1250 g birthweight? (2003) J Perinatol, 23 (8), pp. 673-678; \n\nChow, L.C., Wright, K.W., Sola, A., Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? (2003) Pediatrics, 111 (2), pp. 339-345. , CSMC Oxygen Administration Study Group; \n\nAlme, A.M., Mulhern, M.L., Hejkal, T.W., Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment (2008) BMC Ophthalmol, 8 (1), p. 23; \n\nInternational Committee for the Classification of Retinopathy of Prematurity, The International classification of retinopathy of prematurity revisited (2005) Arch Ophthalmol, 123 (7), pp. 991-999; \n\nAmerican Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, Screening examination of premature infants for retinopathy of prematurity (2006) Pediatrics, 117 (2), pp. 572-576; \n\nSchaffer, D.B., Palmer, E.A., Plotsky, D.F., Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group (1993) Ophthalmology, 100 (2), pp. 230-237; \n\nClark, D., Mandal, K., Treatment of retinopathy of prematurity (2008) Early Hum Dev, 84, pp. 95-99; \n\nWilliam, V.G., Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial (2004) Trans Am Ophthalmol Soc, 102, pp. 233-248. , Early Treatment for Retinopathy of Prematurity Cooperative Group; \n\nSmith, L.E., Pathogenesis of retinopathy of prematurity (2003) Semin Neonatol, 8, pp. 469-473; \n\nChen, J., Smith, L.E., Retinopathy of prematurity (2007) Angiogenesis, 10 (2), pp. 133-140; \n\nChan-Ling, T., Gock, B., Stone, J., Supplemental oxygen therapy: basis for noninvasive treatment of retinopathy of prematurity (1995) Invest Ophthalmol Vis Sci, 36, pp. 1215-1230; \n\nSmith, L.E., Pathogenesis of retinopathy of prematurity (2002) Acta Paediatr Suppl, 91 (437), pp. 26-28; \n\nSmith, L.E., Shen, W., Perruzzi, C., et al, Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor (1999) Nat Med, 5, pp. 1390-1395; \n\nHellstrom, A., Pernuzzi, C., Ju, M., Low IGF-1 suppresses VEGF-a survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity (2001) Proc Natl Acad Sci U S A, 98, pp. 5804-5808; \n\nStout, A.U., Stout, J.T., Retinopathy of prematurity (2003) Pediatr Clin North Am, 50 (1), pp. 77-87; \n\nGu, X.G., El-Remessy, A.B., Brooks, S.E., Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite (2003) Am J Physiol, Cell Physiol, 285, pp. C546-C554; \n\nKim, T.I., Sohn, J., Pi, S.Y., Postnatal risk factors of retinopathy of prematurity (2004) Paediatr Perinat Epidemiol, 18 (2), pp. 130-134; \n\nQuinn, G.E., The 'ideal' management of retinopathy of prematurity (2005) Eye, 19 (10), pp. 1044-1049; \n\nTasman, W., Patz, A., McNamara, J.A., Retinopathy of prematurity: the life of a lifetime disease (2006) Am J Ophthalmol, 141 (1), pp. 167-174; \n\nFlynn, J.T., Acute proliferative retrolental fibroplasia: multivariate risk analysis (1983) Trans Am Ophthalmol Soc, 81, pp. 549-591; \n\nLucey, J.F., Dangman, B., A reexamination of the role of oxygen in retrolental fibroplasia (1984) Pediatrics, 73 (1), pp. 82-96; \n\nBuksh, M.J., Dai, S., Kuschel, C.A., AP-ROP in an infant with minimal oxygen exposure (2008) Paediatr Child Health, 44 (4), pp. 228-230; \n\nCampbell, K., Intensive oxygen therapy as a possible cause of retrolental fibroplasias: a clinical approach (1951) Med J Aust, 2, pp. 48-50; \n\nAshton, N., Cook, C., Direct observation of the effect of oxygen on developing vessels: preliminary report (1954) Br J Ophthalmol, 38, pp. 433-440; \n\nKinsey, V.E., Arnold, H.J., Kalina, R.E., PaO2 levels and retrolental fibroplasia: a report of the cooperative study (1977) Pediatrics, 60 (5), pp. 655-668; \n\nBancalari, E., Flynn, J., Goldberg, R.N., Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity (1987) Pediatrics, 79 (5), pp. 663-669; \n\nCunningham, S., Fleck, B.W., Elton, R.A., Transcutaneous oxygen levels in retinopathy of prematurity (1995) Lancet, 346, pp. 1464-1465; \n\nYork, J.R., Landers, S., Kirby, R.S., Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants (2004) J Perinatol, 24 (2), pp. 82-87; \n\nFlynn, J.T., Bancalari, E., Snyder, E.S., A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity (1992) N Engl J Med, 326 (16), pp. 1050-1054; \n\nHesse, L., Eberl, W., Schlaud, M., Blood transfusion. Iron load and retinopathy of prematurity (1997) Eur J Pediatr, 156, pp. 465-470; \n\nBatton, D.G., Roberts, C., Trese, M., Severe retinopathy of prematurity and steroid exposure (1992) Pediatrics, 90, pp. 534-536; \n\nGallo, J.E., Jacobsen, L., Broberger, U., Perinatal factors associated with retinopathy of prematurity (1993) Acta Paediatr Scand, 82, pp. 829-834; \n\nMcColm, J.R., Fleck, B.W., Retinopathy of prematurity: causation (2001) Semin Neonatol, 6, pp. 453-460; \n\nSTOP-ROP Multicenter Study Group, Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes (2000) Pediatrics, 105 (2), pp. 295-310; \n\nLloyd, J., Askie, L., Smith, J., Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity (2003) Cochrane Database Syst Rev, (2). , CD003482; \n\nHellström, A., Engström, E., Hård, A.L., Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth (2003) Pediatrics, 112 (5), pp. 1016-1020; \n\nBrown, D.R., Milley, J.R., Ripepi, U.J., Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates (1987) Am J Dis Child, 141, pp. 154-160; \n\nMariani, G., Cifuentes, J., Carlo, W.A., Randomised trial of permissive hypercapnia in preterm infants (1999) Pediatrics, 104, pp. 1082-1088; \n\nGellen, B., McIntosh, N., McColm, J.R., Is the partial pressure of carbon dioxide in the blood related to the development of retinopathy of prematurity? (2001) Br J Ophthalmol, 85, pp. 1044-1045; \n\nBerkowitz, B.A., Adult and newborn rat inner retinal oxygenation during carbogen and 100% oxygen breathing (1996) Invest Ophthalmol Vis Sci, 37, pp. 2089-2098; \n\nStiris, T., Odden, J.P., Hansen, T.W., The effect of arterial PCO2-variations on ocular and cerebral blood flow in the newborn piglet (1989) Pediatr Res, 25, pp. 205-208; \n\nCunningham, S., Symon, A.G., Elton, R.A., Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life (1999) Early Hum Dev, 56, pp. 151-165; \n\nSchmidt, B., Davis, P., Moddemann, D., Long-term effects of indomethacin prophylaxis in extremely low-birth-weight infants (2001) N Engl J Med, 344, pp. 1966-1972; \n\nKnight, D.B., The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials (2001) Semin Neonatol, 6, pp. 63-73; \n\nTermote, J., Schalij-Delfos, N.E., Brouwers, H.A., New developments in neonatology: less severe retinopathy of prematurity? (2000) J Pediatr Ophthalmol Strabismus, 37, pp. 142-148; \n\nPenn, J.S., Rajaratnam, V.S., Collier, R.J., The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity (2001) Invest Ophthalmol Vis Sci, 42, pp. 283-290; \n\nTermote, J.U., Schalij-Delfos, N.E., Wittebol-Post, D., Surfactant replacement therapy: a new risk factor in developing retinopathy of prematurity? (1994) Eur J Pediatr, 153, pp. 113-116; \n\nGlass, P., Avery, G.B., Subramanian, K.N., Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity (1985) N Engl J Med, 313 (7), pp. 401-404; \n\nHommura, S., Usuki, Y., Takei, K., Ophthalmologic care of very low birth weight infants. Report 4. clinical studies of the influence of light on the incidence of retinopathy of prematurity (1988) Nippon Ganka Gakkai Zasshi, 92 (3), pp. 456-461; \n\nAckerman, B., Sherwonit, E., Williams, J., Reduced incidental light exposure effect on the development of retinopathy of prematurity in low birth weight infants (1989) Pediatrics, 83 (6), pp. 958-962; \n\nReynolds, J.D., Hardy, R.J., Kennedy, K.A., Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group (1998) N Engl J Med, 338 (22), pp. 1572-1576; \n\nPhelps, D.L., Watts, J.L., Early light reduction for preventing retinopathy of prematurity in very low birth weight infants (2001) Cochrane Database Syst Rev, (1). , CD000122; \n\nConsole, V., Gagliardi, L., De Giorgi, A., Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group (1997) Acta Biomed Ateneo Parmense, 68, pp. 75-79; \n\nHaroon, P.M., Dhanireddy, R., Association of postnatal dexamethasone use and fungal sepsis in the development of severe retinopathy of prematurity and progression to laser therapy in extremely low-birth-weight infants (2001) J Perinatol, 21, pp. 242-247; \n\nHalliday, H.L., Ehrenkranz, R.A., Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (2001) Cochrane Database Syst Rev, (2). , [Cochrane Review] CD001145; \n\nAkkoyun, I., Oto, S., Yilmaz, G., Risk factors in the development of mild and severe retinopathy of prematurity (2006) J AAPOS, 10 (5), pp. 449-453; \n\nDutta, S., Narang, S., Narang, A., Risk factors of threshold retinopathy of prematurity (2004) Indian Pediatr, 41 (7), pp. 665-671; \n\nCooke, R.W., Clark, D., Hickey-Dwyer, M., The apparent role of blood transfusions in the development of retinopathy of prematurity (1993) Eur J Pediatr, 152, pp. 833-836; \n\nDani, C., Reali, M.F., Bertini, G., The role of blood transfusions and iron intake on retinopathy of prematurity (2001) Early Hum Dev, 62, pp. 57-63; \n\nLiu, P.M., Fang, P.C., Huang, C.B., Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g (2005) Am J Perinatol, 22 (2), pp. 115-120; \n\nShah, V.A., Yeo, C.L., Ling, Y.L., Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore (2005) Ann Acad Med Singap, 34 (2), pp. 169-178; \n\nCsak, K., Szabo, V., Szabo, A., Pathogenesis and genetic basis for retinopathy of prematurity (2006) Front Biosci, 1 (11), pp. 908-920; \n\nChiang, M.F., Arons, R.R., Flynn, J.T., Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database (2004) Ophthalmology, 111 (7), pp. 1317-1325; \n\nCooke, R.W., Drury, J.A., Mountford, R., Genetic polymorphisms and retinopathy of prematurity (2004) Invest Ophthalmol Vis Sci, 45 (6), pp. 1712-1715; \n\nO'Keefe, M., Kirwan, C., Screening for retinopathy of prematurity (2008) Early Hum Dev, 84, pp. 89-94; \n\nSubhani, M., Combs, A., Weber, P., Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants (2001) Pediatrics, 107 (4), pp. 656-659; \n\n(2007) UK retinopathy of Prematurity Guideline. 2007, , http://www.rcophth.ac.uk/docs/publications/ROP_Guideline_-_Masterv11-ARF -2.pdf, Available at: Accessed November 28, 2008; \n\nMathew, M.R., Fern, A.I., Hill, R., Retinopathy of prematurity: are we screening too many babies? (2002) Eye, 16 (5), pp. 538-542; \n\nHo, S.F., Mathew, M.R., Wykes, W., Retinopathy of prematurity: an optimum screening strategy (2005) J AAPOS, 9 (6), pp. 584-588; \n\nHutchinson, A.K., O'Neil, J.W., Morgan, E.N., Retinopathy of prematurity in infants with birth weights greater than 1250 grams (2003) J AAPOS, 7 (3), pp. 190-194; \n\nVanderVeen, D.K., Mansfield, T.A., Eichenwald, E.C., Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity (2006) J AAPOS, 10 (5), pp. 445-448; \n\nCoe, K., Butler, M., Reavis, N., Special Premie Oxygen Targeting (SPOT): a program to decrease the incidence of blindness in infants with retinopathy of prematurity (2006) J Nurs Care Qual, 21 (3), pp. 230-235; \n\nMilner, R.A., (1981) Vitamin E supplement in under 1,500 gram neonates. Retinopathy of Prematurity Conference, , Ross Laboratories, Columbus (OH) p. 703-16; \n\nFiner, N.N., Schindler, R.F., Grant, G., Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia: a controlled trial (1982) Lancet, 1 (8281), pp. 1087-1091; \n\nJohnson, L., Quinn, G.E., Abbasi, S., Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial (1989) J Pediatr, 114 (5), pp. 827-838; \n\nRaju, T.N., Langenberg, P., Bhutani, V., Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials (1997) J Pediatr, 131 (6), pp. 844-850; \n\nRosenbaum, A.L., Phelps, D.L., Isenberg, S.J., Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment (1985) Ophthalmology, 92 (8), pp. 1012-1014; \n\nPhelps, D.L., Rosenbaum, A.L., Isenberg, S.J., Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial (1987) Pediatrics, 79 (4), pp. 489-500; \n\nEhrenkranz, R.A., Vitamin E and retinopathy of prematurity: still controversial (1989) J Pediatr, 114 (5), pp. 801-803; \n\nBrion, L.P., Bell, E.F., Raghuveer, T.S., Vitamin E supplementation for prevention of morbidity and mortality in preterm infants (2003) Cochrane Database Syst Rev, (4). , CD003665; \n\nLakatos, L., Hatvani, I., Oroszlan, G., Controlled trial of D-penicillamine to prevent retinopathy of prematurity (1986) Acta Paediatr Hung, 27, pp. 47-56; \n\nLakatos, L., Lakatos, Z., Hatvani, I., Controlled trial of use of D-Penicillamine to prevent retinopathy of prematurity in very low-birth-weight infants (1987) Physiologic foundations of perinatal care, pp. 9-23. , Stern L., Oh W., and Friis-Hansen B. (Eds), Elsevier, St. Louis; \n\nPhelps, D.L., Lakatos, L., Watts, J.L., D-Penicillamine for preventing retinopathy of prematurity in preterm infants (2001) Cochrane Database Syst Rev, (1). , CD001073; \n\nChristensen, R.D., Alder, S.C., Richards, S.C., D-Penicillamine administration and the incidence of retinopathy of prematurity (2007) J Perinatol, 27 (2), pp. 103-111; \n\nHallman, M., Jarvanpaa, A.L., Pohjavuori, M., Respiratory distress syndrome and inositol supplementation in preterm infants (1986) Arch Dis Child, 61, pp. 1076-1083; \n\nHallman, M., Bry, K., Hoppu, K., Inositol supplementation in premature infants with respiratory distress syndrome (1992) N Engl J Med, 326 (19), pp. 1233-1239; \n\nHowlett, A., Ohlsson, A., Inositol for respiratory distress syndrome in preterm infants (2003) Cochrane Database Syst Rev, (4). , CD000366; \n\nSaito, Y., Geisen, P., Uppal, A., Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity (2008) Mol Vis, 13, pp. 840-853; \n\nGeisen, P., Peterson, L.J., Martiniuk, D., Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity (2008) Mol Vis, 14, pp. 345-357; \n\nSteinmetz, R.L., Brooks Jr., H.L., Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity (2002) Retina, 22 (1), pp. 48-52; \n\nHubbard III, G.B., Surgical management of retinopathy of prematurity (2008) Curr Opin Ophthalmol, 19 (5), pp. 384-390; \n\nEarly Treatment For Retinopathy Of Prematurity Cooperative Group, Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial (2003) Arch Ophthalmol, 121 (12), pp. 1684-1694; \n\nWallace, D.K., Quinn, G.E., Freedman, S.F., Agreement among pediatric ophthalmologists in diagnosing plus and preplus disease in retinopathy of prematurity (2008) J AAPOS, 12 (4), pp. 352-356; \n\nJohnson, K.S., Mills, M.D., Karp, K.A., Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease (2007) Am J Ophthalmol, 143, pp. 723-725; \n\nWallace, D.K., Freedman, S.F., Zhao, Z., Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity (2007) Arch Ophthalmol, 125, pp. 1523-1530; \n\nSwanson, C., Cocker, K.D., Parker, K.H., Semiautomated computer analysis of vessel growth in preterm infants without and with ROP (2003) Br J Ophthalmol, 87, pp. 1474-1477; \n\nCoats, D., Saunders, R., The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity (2005) Arch Ophthalmol, 123, pp. 408-409; \n\nFielder, A.R., Cryotherapy of retinopathy of prematurity (1992) Recent advances in ophthalmology, 8, pp. 129-148. , Davidson S.I., and Jay B. (Eds), Churchill Livingstone, Edinburgh (UK); \n\nHutcheson, K.A., Retinopathy of prematurity (2003) Curr Opin Ophthalmol, 14 (5), pp. 286-290; \n\nPhelps, D.L., Retinopathy of prematurity (1992) Curr Probl Pediatr, 22 (8), pp. 349-371; \n\nCryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome (1990) Arch Ophthalmol, 108 (2), pp. 195-204; \n\nCryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter trial of cryotherapy for retinopathy of prematurity: one-year outcome-structure and function (1990) Arch Ophthalmol, 108 (10), pp. 1408-1416; \n\nCryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years (2001) Arch Ophthalmol, 119 (8), pp. 1110-1118; \n\nHiggins, R., Retinopathy of prematurity (2006) E-Medicine, , http://www.emedicine.com/ped/topic1998.htm, Accessed March 25, 2007; \n\nNg, E.Y., Connolly, B.P., McNamara, J.A., A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome (2002) Ophthalmology, 109 (5), pp. 928-934; \n\nConnolly, B.P., Ng, E.Y., McNamara, J.A., A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome (2002) Ophthalmology, 109 (5), pp. 936-941; \n\nPaysse, E.A., Lindsey, J.L., Coats, D.K., Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity (1999) J AAPOS, 3 (4), pp. 234-240; \n\nHunter, D.G., Repka, M.X., Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study (1993) Ophthalmology, 100 (2), pp. 238-244; \n\nLaser ROP Study Group, Laser therapy for retinopathy of prematurity (1994) Arch Ophthalmol, 112, pp. 154-156; \n\nLing, C.S., Fleck, B.W., Wright, E., Diode laser treatment for retinopathy of prematurity: structural and functional outcome (1995) Br J Ophthalmol, 79, pp. 637-641; \n\nWhite, J.E., Repka, M.X., Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: 3-year outcome (1997) J Pediatr Ophthalmol Strabismus, 34, pp. 83-87; \n\nShalev, B., Farr, A.K., Repka, M.X., Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome (2001) Am J Ophthalmol, 132, pp. 76-80; \n\nAndersen, C.C., Phelps, D.L., Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants (2000) Cochrane Database Syst Rev, (2). , CD001693; \n\nPhelps, D.L., Retinopathy of prematurity: A practical clinical approach (2001) NeoReviews, 2 (7), pp. e174-e179; \n\nMcNamara, J.A., Laser treatment for retinopathy of prematurity (1993) Curr Opin Ophthalmol, 4, pp. 76-80; \n\nTopilow, H.W., Ackerman, A.L., Cryotherapy for stage 3+ retinopathy of prematurity: visual and anatomic results (1989) Ophthalmic Surg, 20 (12), pp. 864-871; \n\nNoorily, S.W., Small, K., de Juan Jr., E., Scleral buckling surgery for stage 4B retinopathy of prematurity (1992) Ophthalmology, 99, pp. 263-268; \n\nTrese, M.T., Scleral buckling for retinopathy of prematurity (1994) Ophthalmology, 101, pp. 23-26; \n\nHinz, B.J., deJuan Jr., E., Repka, M.X., Scleral buckling surgery for active stage 4A retinopathy of prematurity (1998) Ophthalmology, 105, pp. 1827-1830; \n\nHubbard III, G.B., Cherwick, D.H., Burian, G., Lens-sparing vitrectomy for stage 4 retinopathy of prematurity (2004) Ophthalmology, 111, pp. 2274-2277; \n\nLakhanpal, R.R., Sun, R.L., Albini, T.A., Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity (2005) Ophthalmology, 112, pp. 1569-1573; \n\nPrenner, J.L., Capone Jr., A., Trese, M.T., Visual outcomes after lens sparing vitrectomy for stage 4A retinopathy of prematurity (2004) Ophthalmology, 111, pp. 2271-2273; \n\nRepka, M.X., Tung, B., Good, W.V., Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP) (2006) Arch Ophthalmol, 124 (1), pp. 24-30; \n\nSears, J.E., Sonnie, C., Anatomic success of lens-sparing vitrectomy with and without scleral buckle for stage 4 retinopathy of prematurity (2007) Am J Ophthalmol, 143 (5), pp. 810-813; \n\nFerrone, P.J., Harrison, C., Trese, M.T., Lens clarity after lens-sparing vitrectomy in a pediatric population (1997) Ophthalmology, 104, pp. 273-278; \n\nLakhanpal, R.R., Davis, G.H., Sun, R.L., Lens clarity after threeport lens-sparing vitrectomy in stage 4A and 4B retinal detachments secondary to retinopathy of prematurity (2006) Arch Ophthalmol, 124 (1), pp. 20-23; \n\nHartnett, M.E., Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity (2003) Retina, 23 (3), pp. 322-329; \n\nSpaide, R.F., Fisher, Y.L., Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage (2006) Retina, 26, pp. 275-278; \n\nAvery, R.L., Pieramici, D.J., Rabena, M.D., Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration (2006) Ophthalmology, 113, pp. 363e5-372e5; \n\nChung, E.J., Kim, J.H., Ahn, H.S., Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity (2007) Graefes Arch Clin Exp Ophthalmol, 245, pp. 1727-1730; \n\nShah, P.K., Narendran, V., Tawansy, K.A., Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity (2007) Indian J Ophthalmol, 55, pp. 75-76; \n\nTravassos, A., Teixeira, S., Ferreira, P., Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity (2007) Ophthalmic Surg Lasers Imaging, 38, pp. 233-237; \n\nCryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomisation (1996) Arch Ophthalmol, 114, pp. 417-442; \n\nRuth, A., Hutchinson, A.K., Hubbard III, G.B., Late vitreous hemorrhage in patients with regressed retinopathy of prematurity (2008) J AAPOS, 12, pp. 181-185; \n\nTasman, W., Brown, G.C., Progressive visual loss in adults with retinopathy of prematurity (ROP) (1988) Trans Am Ophthalmol Soc, 86, pp. 367-379; \n\nCats, B.P., Tan, K.E., Prematures with and without regressed retinopathy of prematurity: comparison of long-term (6-10 years) ophthalmological morbidity (1989) J Pediatr Ophthalmol Strabismus, 26 (6), pp. 271-275; \n\nCryotherapy for Retinopathy of Prematurity Cooperative Group, Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g (2002) Arch Ophthalmol, 120 (5), pp. 595-599", "hasCitationDuplums" : false, "userChangeableUntil" : "2015-12-20T11:56:44.000+0000", "publishDate" : "2015-09-21T10:56:44.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 7, "ownerInstituteCount" : 25, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "hasQualityFactor" : false, "link" : "/api/publication/25034186", "label" : "Askin DF et al. Retinopathy of Prematurity. (2009) CRITICAL CARE NURSING CLINICS OF NORTH AMERICA 0899-5885 1558-3481 21 2 213-233", "template" : "